보포스트 그룹
평가액
$7.328B
보유 종목
38
상위 10 비중
74.8%
매수
| 종목 | 구분 | 직전 수량 | 수량 | 수량 변화 | 직전 평가액 | 평가액 | 평가액 차이 | 비중 |
|---|---|---|---|---|---|---|---|---|
| CITIGROUP INC | 신규 | 0 | 5,167,000 | +5,167,000 | $0 | $219M | +$219M | 3.0% |
| E M C CORP MASS | 추가 | 51,851,500 | 56,961,725 | +5,110,225 | $1.382B | $1.548B | +$165.8M | 21.1% |
| Liberty Ventures Series A | 신규 | 0 | 2,469,533 | +2,469,533 | $0 | $91.55M | +$91.55M | 1.2% |
| ALLERGAN PLC | 추가 | 1,721,587 | 2,001,978 | +280,391 | $461.4M | $462.6M | +$1.2M | 6.3% |
| AVIS BUDGET GROUP | 신규 | 0 | 1,787,227 | +1,787,227 | $0 | $57.6M | +$57.6M | 0.8% |
| LIBERTY MEDIA CORP DELAWARE | 신규 | 0 | 2,994,010 | +2,994,010 | $0 | $43.89M | +$43.89M | 0.6% |
| SILVER RUN ACQUISITION CORP | 신규 | 0 | 3,750,000 | +3,750,000 | $0 | $36.75M | +$36.75M | 0.5% |
| CASCADIAN THERAPEUTICS INC | 신규 | 0 | 25,000,000 | +25,000,000 | $0 | $23.58M | +$23.58M | 0.3% |
| CREDIT ACCEP CORP MICH | 신규 | 0 | 100,000 | +100,000 | $0 | $18.51M | +$18.51M | 0.3% |
| THERAVANCE BIOPHARMA INC | 추가 | 6,500,991 | 7,350,991 | +850,000 | $122.2M | $166.8M | +$44.58M | 2.3% |
| OCH ZIFF CAP MGMT GROUP | 신규 | 0 | 3,373,891 | +3,373,891 | $0 | $12.82M | +$12.82M | 0.2% |
| LIBERTY MEDIA CORP DELAWARE | 신규 | 0 | 800,000 | +800,000 | $0 | $12.03M | +$12.03M | 0.2% |
| AMERICAN INTL GROUP INC | 추가 | 2,124,551 | 2,550,917 | +426,366 | $39.73M | $47.68M | +$7.948M | 0.7% |
| PARATEK PHARMACEUTICALS INC | 추가 | 1,544,498 | 2,044,498 | +500,000 | $23.43M | $28.44M | +$5.009M | 0.4% |
| SILVER RUN ACQUISITION CORP | 신규 | 0 | 1,250,000 | +1,250,000 | $0 | $1.425M | +$1.425M | 0.0% |